272 - Special Session: How the Study & Practice of Infectious Diseases Will Continue to Change the World

Saturday, October 19, 2024

4:45 PM – 5:30 PM US PT

Location: Ballroom (West Hall B)

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 0.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 0.75 hours of MOC Credit
CNE Credits: Maximum of 0.75 hours of ANCC Credit
ACPE Credits: ACPE 0.75 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Emily Erbelding, MD (she/her/hers)

Director, Division of Microbiology and Infectious Disease NIAID
National Institutes of Health
Rockville, MD, United States

Plenary Speaker(s)

Jeanne Marrazzo, MD, FIDSA

Director of the National Institute of Allergy and Infectious Diseases
U.S. National Institutes of Health

Slides

Disclosure(s):

Emily Erbelding, MD: No financial relationships to disclose

Jeanne Marrazzo, MD, FIDSA: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

analyze current trends in infectious disease research and practice and their implications for global health;
identify key innovations in diagnostics, treatment, and prevention that are shaping the future of infectious disease management;
discuss the impact of emerging infectious diseases on global health policies and practices, emphasizing the importance of interdisciplinary collaboration.